Live
Endpoints NewsAmgen stands by rare disease drug Tavneos amid Japan liver toxicity reportEndpoints NewsFDA's unreleased Covid vaccine deaths report is published by lawmaker10x Genomics NewsThe 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo FinanceBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-May 15, 2026BioPharma DiveFDA approves AstraZeneca’s new kind of hypertension drugBioWorldAuthorities work to quickly sequence Ebola species in latest outbreakBioPharma DiveMerck ADC, licensed from China, hits mark in first big global trialBoston ScientificBoston Scientific buys $1.5B stake in TAVR developer MiRus - MedTech DiveThermo FisherThermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with Ne - PharmiWeb.comEndpoints NewsRegeneron reaches $125M Parabilis deal for hard-to-catch drug targetsFierceBiotechBioMarin’s $270M Inozyme bet looks in trouble after rare disease drug misses key ph. 3 goal

Archive

Latest Oldest
Total 11428
Page 504 / 635
Query --